Assessment of melanoma-initiating cell markers and conventional parameters in sentinel lymph nodes of malignant melanoma

Norihiro Suzuki, Minora Takat, Yoshinori Shirafuji, Masaki Otsuka, Osamu Yamasaki, Kenji Asagoe, Naohito Hatta, Keiji Iwatsuki

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Sentinel lymph node (SLN) biopsies have widely been used for the detection of occult LN metastasis of malignant melanoma (MM). In addition to conventional biomarkers, we assessed the diagnostic and prognostic significance of melanoma-initiating cell (MIC) markers in SLNs of MM. We examined the expressions of gp100, MARTI-1 and tyrosinase mRNA for routine diagnosis and those of ABCB5, CD133, nestin, KDM5B, NGFR and RANK mRNA as MIC markers. The presence of micrometastasis was confirmed immunohistochemically using antibodies to S-100, HMB-45, MARTI-1, and tyrosinase. Discordance between immunohistochemical and molecular data was observed in 14 of 70 (20.0%) patients, among whom five (7.1 %) were positive for only molecular markers; two of these five patients tested positive for micrometastasis by repeated immunohistochemical stainings. The quantitative expression levels of gpl00, MARTI-1, and tyrosinase mRNA were significantly higher in the metastatic LNs; the cut-off values remain to be elucidated. ABCB5 mRNA expression was detected more frequently in the metastatic SLNs (p <0.05) and in the group of patients with recurrence. To make a definite diagnosis of metastasis, we still need a combination of immunohistochemical and molecular probes. ABCB5 might be a suitable molecular marker for the detection of melanoma-initiating cells in SLNs.

Original languageEnglish
Pages (from-to)17-27
Number of pages11
JournalActa Medica Okayama
Volume69
Issue number1
Publication statusPublished - 2015

Fingerprint

Monophenol Monooxygenase
Melanoma
Messenger RNA
Neoplasm Micrometastasis
Molecular Probes
Nestin
Biopsy
Neoplasm Metastasis
Biomarkers
Sentinel Lymph Node Biopsy
Sentinel Lymph Node
cyhalothrin
Antibodies
Staining and Labeling
Recurrence

Keywords

  • ABCB5
  • Cancer-initiating cell
  • melanoma
  • Sentinel lymph node

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Suzuki, N., Takat, M., Shirafuji, Y., Otsuka, M., Yamasaki, O., Asagoe, K., ... Iwatsuki, K. (2015). Assessment of melanoma-initiating cell markers and conventional parameters in sentinel lymph nodes of malignant melanoma. Acta Medica Okayama, 69(1), 17-27.

Assessment of melanoma-initiating cell markers and conventional parameters in sentinel lymph nodes of malignant melanoma. / Suzuki, Norihiro; Takat, Minora; Shirafuji, Yoshinori; Otsuka, Masaki; Yamasaki, Osamu; Asagoe, Kenji; Hatta, Naohito; Iwatsuki, Keiji.

In: Acta Medica Okayama, Vol. 69, No. 1, 2015, p. 17-27.

Research output: Contribution to journalArticle

Suzuki, N, Takat, M, Shirafuji, Y, Otsuka, M, Yamasaki, O, Asagoe, K, Hatta, N & Iwatsuki, K 2015, 'Assessment of melanoma-initiating cell markers and conventional parameters in sentinel lymph nodes of malignant melanoma', Acta Medica Okayama, vol. 69, no. 1, pp. 17-27.
Suzuki, Norihiro ; Takat, Minora ; Shirafuji, Yoshinori ; Otsuka, Masaki ; Yamasaki, Osamu ; Asagoe, Kenji ; Hatta, Naohito ; Iwatsuki, Keiji. / Assessment of melanoma-initiating cell markers and conventional parameters in sentinel lymph nodes of malignant melanoma. In: Acta Medica Okayama. 2015 ; Vol. 69, No. 1. pp. 17-27.
@article{200d4342b2a34d90a80fee505a1f8397,
title = "Assessment of melanoma-initiating cell markers and conventional parameters in sentinel lymph nodes of malignant melanoma",
abstract = "Sentinel lymph node (SLN) biopsies have widely been used for the detection of occult LN metastasis of malignant melanoma (MM). In addition to conventional biomarkers, we assessed the diagnostic and prognostic significance of melanoma-initiating cell (MIC) markers in SLNs of MM. We examined the expressions of gp100, MARTI-1 and tyrosinase mRNA for routine diagnosis and those of ABCB5, CD133, nestin, KDM5B, NGFR and RANK mRNA as MIC markers. The presence of micrometastasis was confirmed immunohistochemically using antibodies to S-100, HMB-45, MARTI-1, and tyrosinase. Discordance between immunohistochemical and molecular data was observed in 14 of 70 (20.0{\%}) patients, among whom five (7.1 {\%}) were positive for only molecular markers; two of these five patients tested positive for micrometastasis by repeated immunohistochemical stainings. The quantitative expression levels of gpl00, MARTI-1, and tyrosinase mRNA were significantly higher in the metastatic LNs; the cut-off values remain to be elucidated. ABCB5 mRNA expression was detected more frequently in the metastatic SLNs (p <0.05) and in the group of patients with recurrence. To make a definite diagnosis of metastasis, we still need a combination of immunohistochemical and molecular probes. ABCB5 might be a suitable molecular marker for the detection of melanoma-initiating cells in SLNs.",
keywords = "ABCB5, Cancer-initiating cell, melanoma, Sentinel lymph node",
author = "Norihiro Suzuki and Minora Takat and Yoshinori Shirafuji and Masaki Otsuka and Osamu Yamasaki and Kenji Asagoe and Naohito Hatta and Keiji Iwatsuki",
year = "2015",
language = "English",
volume = "69",
pages = "17--27",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "1",

}

TY - JOUR

T1 - Assessment of melanoma-initiating cell markers and conventional parameters in sentinel lymph nodes of malignant melanoma

AU - Suzuki, Norihiro

AU - Takat, Minora

AU - Shirafuji, Yoshinori

AU - Otsuka, Masaki

AU - Yamasaki, Osamu

AU - Asagoe, Kenji

AU - Hatta, Naohito

AU - Iwatsuki, Keiji

PY - 2015

Y1 - 2015

N2 - Sentinel lymph node (SLN) biopsies have widely been used for the detection of occult LN metastasis of malignant melanoma (MM). In addition to conventional biomarkers, we assessed the diagnostic and prognostic significance of melanoma-initiating cell (MIC) markers in SLNs of MM. We examined the expressions of gp100, MARTI-1 and tyrosinase mRNA for routine diagnosis and those of ABCB5, CD133, nestin, KDM5B, NGFR and RANK mRNA as MIC markers. The presence of micrometastasis was confirmed immunohistochemically using antibodies to S-100, HMB-45, MARTI-1, and tyrosinase. Discordance between immunohistochemical and molecular data was observed in 14 of 70 (20.0%) patients, among whom five (7.1 %) were positive for only molecular markers; two of these five patients tested positive for micrometastasis by repeated immunohistochemical stainings. The quantitative expression levels of gpl00, MARTI-1, and tyrosinase mRNA were significantly higher in the metastatic LNs; the cut-off values remain to be elucidated. ABCB5 mRNA expression was detected more frequently in the metastatic SLNs (p <0.05) and in the group of patients with recurrence. To make a definite diagnosis of metastasis, we still need a combination of immunohistochemical and molecular probes. ABCB5 might be a suitable molecular marker for the detection of melanoma-initiating cells in SLNs.

AB - Sentinel lymph node (SLN) biopsies have widely been used for the detection of occult LN metastasis of malignant melanoma (MM). In addition to conventional biomarkers, we assessed the diagnostic and prognostic significance of melanoma-initiating cell (MIC) markers in SLNs of MM. We examined the expressions of gp100, MARTI-1 and tyrosinase mRNA for routine diagnosis and those of ABCB5, CD133, nestin, KDM5B, NGFR and RANK mRNA as MIC markers. The presence of micrometastasis was confirmed immunohistochemically using antibodies to S-100, HMB-45, MARTI-1, and tyrosinase. Discordance between immunohistochemical and molecular data was observed in 14 of 70 (20.0%) patients, among whom five (7.1 %) were positive for only molecular markers; two of these five patients tested positive for micrometastasis by repeated immunohistochemical stainings. The quantitative expression levels of gpl00, MARTI-1, and tyrosinase mRNA were significantly higher in the metastatic LNs; the cut-off values remain to be elucidated. ABCB5 mRNA expression was detected more frequently in the metastatic SLNs (p <0.05) and in the group of patients with recurrence. To make a definite diagnosis of metastasis, we still need a combination of immunohistochemical and molecular probes. ABCB5 might be a suitable molecular marker for the detection of melanoma-initiating cells in SLNs.

KW - ABCB5

KW - Cancer-initiating cell

KW - melanoma

KW - Sentinel lymph node

UR - http://www.scopus.com/inward/record.url?scp=84923493437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923493437&partnerID=8YFLogxK

M3 - Article

C2 - 25703167

AN - SCOPUS:84923493437

VL - 69

SP - 17

EP - 27

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 1

ER -